期刊文献+

冠状动脉再次血运重建患者血清对氧磷酶-1的活性研究

Serum paraoxonase-1 activity in patients undergoing repeat coronary revascularizations
下载PDF
导出
摘要 目的了解血清对氧磷酶-1活性水平对再次冠状动脉血运重建的预测价值。方法以比色法测定200例行经皮冠状动脉介入治疗获得完全血运重建患者的血清对氧磷酶-1活性水平。术后随访1年,在首次介入手术后第6个月进行造影随访。将随访期内需要再次血运重建的患者归入再次血运重建组,无需再次血运重建的患者归入单次血运重建组,同期冠状动脉造影排除冠状动脉粥样硬化性心脏病(冠心病)患者100例作为非冠心病对照组。分析各组血清对氧磷酶-1活性水平的差异。结果再次血运重建组62例,单次血运重建组138例。所有患者均完成1年随访,6个月冠状动脉造影复查率88.5%(177/200),12个月造影复查率69%(138/200)。再次血运重建组、单次血运重建组、非冠心病组的血清对氧磷酶-1活性水平值分别为(109.2±98.6)μkat/L、(132.8±79.4)μkat/L、(156.4±82.8)μkat/L,方差分析示3组血清对氧磷酶-1活性水平差异有统计学意义(P<0.05)。结论冠心病再次血运重建组血清对氧磷酶-1活性水平低于单次血运重建组和非冠心病对照组,故血清对氧磷酶-1活性水平对预测RCR有重要的价值。 Objectives To illuminate the value of paraoxonase-1 (PON 1 ) in predicting repeat coronary revascularization (RCR). Methods Serum PON1 activity of 200 patients who had achieved complete revascularizations in first percutaneous coronary intervention (PCI) was determined by colorimetric method. All patients received one-year follow- up. Coronary angiographies were performed in the 6th month after first procedures. Patients who need more revascularization procedures during follow-up were enrolled in RCR group, those who did not need were enrolled in single coronary revascularization (SCR) group. One hundred patients with normal coronary angiography results during the same period were included in non-coronary heart disease control group (NCC). Serum PON1 activity of the 3 groups was analyzed and compared. Results Sixty two patients were enrolled in RCR group and 138 patients in SCR group. All patients finished one-year follow-up. Proportion of patients who received coronary artery angiography after follow-up for 6 months was 88.5%(177/200), and that of 12 months was 69%(138/200). Serum PON1 activities in RCR group, SCR group and NCC group were ( 109.2 ±98.6 ) μkat/L, ( 132.8 ±79.4) μkat/L and ( 156.4±82.8 ) μkat/L, respectively. Statistic differences were found among three groups (P〈0.05). Conclusions Serum PON-1 activity is lower in patients who need RCR than in patients need SCR or without coronary heart disease, and thus it may be valuable to predict RCR.
出处 《岭南心血管病杂志》 2010年第5期391-393,共3页 South China Journal of Cardiovascular Diseases
基金 深圳市卫生局2009年科研立项:对氧磷酶-1与多次冠脉血运重建风险的相关性研究(编号200903204)
关键词 冠状动脉疾病 对氧磷酶 冠状动脉血运重建 coronary heart disease paraoxonase coronary revascularization
  • 相关文献

参考文献10

  • 1吕树铮,宋现涛,陈韵岱,陈欣,中国经皮冠状动脉介入治疗登记调查研究协作组.中国大陆2005年度经皮冠状动脉介入治疗登记调查研究结果初步分析[J].中华心血管病杂志,2006,34(11):966-970. 被引量:43
  • 2KEVIN E,KIP MARTIAL G,BOURASSA ALICE K,et al. Influence of Pre-PTCA strategy and initial PTCA result in patients with muhivessel disease the bypass angioplasty revasculafization investigation ( BARI ) [ J ] .Circulation, 1999, 100(9) :910-917.
  • 3MARCEL M, BENNO M, MARIE-ANGELE M, et al. The effect of completeness of revascularization on event-free survival at one year in the arts trial [J ]. J Am Coil Cardiol, 2002,39 (4): 559-564.
  • 4TOMAS M,LATORRE G,SENTI M,et al. The antioxidant function of high density lipoproteins: A new paradigm in atherosclerosis [ J ]. Rev Esp Cardiol, 2004,57 (6) : 557-569.
  • 5MACKNESS B, DAVIES G K,TURKIC W,et al. Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype? [J]. Arterioscler Thromb Vasc Biol, 2001,21 (9) : 1451-1457.
  • 6苏显明,崔长琮,崔翰斌,王新阳.冠心病患者血清对氧磷酶活性的测定[J].中国动脉硬化杂志,2006,14(6):521-523. 被引量:4
  • 7GRANER M,JAMES R W,KAHRI J,et al. Association of paraoxonase-1 activity and concentration with angiographic severity and extent of coronary artery disease [ J ]. J Am Coll Cardiol, 2006,47 ( 12 ) : 2429-2435.
  • 8YILDZ A, SEZEN Y, GUR M,et al. Association of paraoxonase activity and coronary collateral flow [J ]. Coronary Artery Dis, 2008,19 (7) : 441-447.
  • 9MOHAMED R H, MOHAMED R H, KARAM R A,et al. The relationship between paraoxonasel- 192 polymorphism and activity with coronary artery disease [J~. Clin Biochem,2010, 43(6) :553-558.
  • 10BIRJMOHUN R S,VERGEER M,STROES E S,et al. Both paraoxonase-1 genotype and activity do not predict the risk of future coronary artery disease; the EPIC-Norfolk Prospective Population Study [ J ]. PLoS One, 2009,4 ( 8 ) : e6809.

二级参考文献15

  • 1Castelli WP.Lipid,risk factors and ischaemic heart disease[J].Atherosclerosis,1996,124(Suppl):S1-S9
  • 2Gordon DJ,Probstfield JL,Garrison RJ,Nsaton JD,Castelli WP,Knoke JD,et al.High-density lipoprotein cholesterol and cardiovascular disease:fore prospective American studies[J].Circulation,1989,79:8-15
  • 3Navab M,Ananthramaiah GM,Reddy ST,Van Lenten BJ,Ansel BJ,Fonarow GC,et al.Thematic review series:the pathogenesis of atherosclerosis:the oxidation hypothesis of atherogenesis:the role of oxidized phospholipids and HDL[J].J Lipid Res,2004,45:993-1 007
  • 4Navab M,Hama Y,Cookw CJ,Ananthramaiah GM,Chaddha M,Jin L,et al.Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein:steps1[J].J Lipid Res,2000,41:1 481-494
  • 5Navab M,Hama SY,Ananthramaiah GM,Hassan K,Hough GP,Watson AD,et al.Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein:steps2 and 3[J].J Lipid Res,2000,41:1 495-508
  • 6Drrington PN,Mackness B,Mackness MI.Paraoxonase and atherosclerosis[J].Arterioscler Thromb Vasc Biol,2001,21:473-480
  • 7Watson AD,Berliner JA,Hama SY.Protective effect of high density lipoprotein associated paraoxonase.J Clin Invest,1995,96:2 882-891
  • 8高润霖.中国冠心病介入冶疗现状.中国医学论坛报,2003-11-20(2).
  • 9van Domburg RT, Lemos PA,Takkenberg JM, et al. The impact of the introduction of drug-eluting stents on the clinical practice of surgical and percutaneous treatment of coronary artery disease. Eur Heart J,2005,26:675-681.
  • 10中华人民共和国卫生部.中国卫生统计提要.2005.

共引文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部